Evaluation of multiple sclerosis by 1H spectroscopic imaging at 4.1 T

Magnetic Resonance in Medicine

Volumn 36, Issue 1, 1996, Pages 72-77

  Pan, Jullie W ^a,c   Hetherington, Hoby P ^b   Vaughan, J Thomas ^b   Mitchell, Galen ^a   Pohost, Gerald M ^b   Whitaker, John N ^a,c  

^a The University of Alabama at Birmingham   (United States)

^b University of Alabama at Birmingham   (United States)

^c UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

creatine; magnetic resonance spectroscopy; multiple sclerosis; N acetylaspartate

Indexed keywords

MAGNETIC RESONANCE SPECTROSCOPY; METABOLITES; TISSUE;

CREATINE; MOST LIKELY; MULTIPLE SCLEROSIS; N-ACETYLASPARTATE; NORMAL CONTROLS; RELAPSING-REMITTING MULTIPLE SCLEROSIS; SPECTROSCOPIC IMAGING; WHITE MATTER;

MAGNETIC RESONANCE;

CHOLINE; CREATINE; N ACETYLASPARTIC ACID;

ADULT; ARTICLE; CEREBROSPINAL FLUID ANALYSIS; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GRAY MATTER; HUMAN; MALE; MULTIPLE SCLEROSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; PROTON NUCLEAR MAGNETIC RESONANCE; WHITE MATTER;

EID: 0029950976     PISSN: 07403194     EISSN: None     Source Type: Journal    
DOI: 10.1002/mrm.1910360113     Document Type: Article

References (28)

1. V. Sanders, A. J. Conrad. W. W. Tourtellotte, On classification of post mortem multiple sclerosis plaques for neuroscientists. J. Neuroimmunol. 46, 207-216 (1993).
2. J. W. Prineas, R. O. Barnard, T. Revesz, E. E. Kwon, L. Sharer, E.-S. Cho, Multiple sclerosis pathology of recurrent lesions. Brain 116, 681-693 (1993).
3. I. E. C. Ormerod, D. H. Miller, W. I. McDonald, E. P. G. H. du Boulay, P. Rudge, B. E. Kendall, J. F. Moseley, G. Johnson, P. S. Tofts, A. M. Halliday, A. M. Bronstein, F. Scaravilli, A. E. Harding, D. Barnes, K. J. Zilkha, The role of NMR imaging in the assessment of multiple sclerosis and isolated neurological lesions. Brain 110, 1579-1616 (1987).
4. D. L. Arnold, P. M. Matthews, G. Francis, J. Antel, Proton magnetic resonance spectroscopy of human brain in vivo in the evaluation of multiple sclerosis: assessment of the load of disease. Magn. Reson. Med. 14, 154-159 (1990).
5. P. M. Matthews, G. S. Francis, J. P. Antel, D. L. Arnold, Proton magnetic resonance spectroscopy for metabolic characterization of plaques in multiple sclerosis. Neurology 41, 1251-1256 (1991).
6. 1H spoctroscopic imaging. Ann. Neurol. 36, 157-165 (1994).
7. C. A. Davie, C. P. Hawkins, G. J. Barker, A. Brennan, P. S. Tofts, D. H. Miller, W. I. McDonald, Serial proton magnetic resonance spectroscopy in acute multiple sclerosis. Brain 117, 49-58 (1994).
8. J. W. Pan, H. P. Hetherington, G. F. Mason, J. N. Whitaker, G. M. Pohost, Evaluation of multiple sclerosis by high field spectroscopic imaging, in "Proc., SMRM, 12th Annual Meeting, 1993," p. 1552.
9. J. Urenjak, S. R. Williams, D. G. Gadian, M. Noble, Proton nuclear magnetic resonance spectroscopy unambiguously identifies different neural cell types. J. Neurosci. 13, 981-989 (1993).
10. D. L. Arnold, G. R. Riess, P. M. Matthews, G. S. Francis, D. L. Collins, C. Wolfson, J. P. Antel, Use of proton magnetic resonance spectroscopy for monitoring disease progression in multiple sclerosis. Ann. Neurol. 36, 76-82 (1994).
11. R. I. Grossman, R. E. Lenkinski, K. N. Ramer, Gonzalez-F. Scarano, J. A. Cohen, Magnetic resonance proton spectroscopy in multiple sclerosis. AJNR Am. J. Neuroradiol. 13, 1535-1543 (1992).
12. H. B. W. Larsson, C. P. Hristiansen, M. Jensen, J. Frederiksen, A. Heltberg, J. Olesen, Localized in vivo proton spectroscopy in the brain of patients with multiple sclerosis. Magn. Reson. Med. 22, 23-31 (1981).
13. D. L. Arnold, P. M. Matthews, G. S. Francis, J. O'Connor, J. P. Antel, Proton magnetic resonance spectroscopic imaging for metabolic characterization of demyelinating plaques. Ann. Neurol 31, 235-241 (1992).
14. J. F. Kurtzke, Rating neurological impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology 33, 1444-1452 (1983).
15. J. T. Vaughan, H. P. Hetherington, J. O. Otu, J. W. Pan, G. M. Pohost, High frequency volume coils for clinical NMR imaging and spectroscopy. Magn. Reson. Med. 32, 206-218 (1994).
16. H. P. Hetherington, J. W. Pan, G. F. Mason, S. L. Ponder, D. B. Twieg, G. Deutsch, J. Mountz, G. M. Pohost, 2D spectroscopic imaging of the human brain at 4.1T. Magn. Reson. Med. 32, 530-534 (1994).
17. H. P. Hetherington, G. F. Mason, J. W. Pan, S. L. Ponder, J. T. Vaughan, D. B. Twieg, G. M. Pohost, Evaluation of cerebral gray and white matter metabolic differences by spectroscopic imaging at 4.1T. Magn. Reson. Med. 32, 565-571 (1994).
18. K. Baum, C. Nehrig, W. Schorner, W. Girke, Periventricular plaques in multiple sclerosis: irreversible? An MRI follow-up study. Eur. Neurol. 32, 219-221 (1992).
19. R. Kreis, T. Ernst, B. D. Ross, Absolute quantitation of water and metabolites in human brain II. metabolite concentrations. J. Magn. Reson. B 102, 9-19 (1993).
20. J. W. Prineas, The neuropathology of multiple sclerosis, in "Handbook of Clinical Neurology, Vol. 47, Demyelinating Diseases", pp. 213-257, Elsevier Publishing Company, New York, 1985.
21. I. V. Allen, S. R. McKeown, A histological, histochemical and biochemical study of the macroscopically normal white matter in multiple sclerosis. J. Neurol. Sci. 41, 81-91 (1979).
22. Lopez-D. Villegas, R. E. Lenkinski, S. L. Wehrli, W. Z. Ho, S. D. Douglas, Lactate production by human monocytes/macrophages determined by proton MR spectroscopy. Magn. Reson. Med. 34, 32-38 (1995).
23. 1H NMR of acid extracts. Biochim. Biophys. Acta 1054, 181-197 (1990).
24. H. Lassmann, G. Suchanek, K. Ozawa, Histopathology and the blood-CSF barrier in multiple sclerosis. Ann. Neurol. 36(Suppl), S42-S46 (1994).
25. R. E. Brenner, P. M. G. Munro, S. C. R. Williams, G. J. Barker, D. H. Miller, D. N. Landon, W. I. McDonald, Abnormal neuronal mitochondria: a cause of reduction in NA in demyelinating disease, in "Proc., SMRM, 12th Annual Meeting, 1993," p. 281.
26. 1-weighted images. AJNR Am. J. Neuroradiol. 16, 69-77 (1995).
27. J. N. Whitaker, R. D. Kachelhofer, E. L. Bradley, S. Burgard, B. A. Layton, A. T. Reder, W. Morrison, G. J. Zhao, D. W. Paty, Urinary myelin basic protein-like material as a correlate of the progression of multiple sclerosis. Ann. Neurol. 38, 625-632 (1995).
28. Greenfield, Demyelinating diseases, in "Textbook of Neuropathology" (J. H. Adams, L. W. Duchen, Eds.), 5th ed., p. 464, Oxford University Press, New York, 1992.